| Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis | |
| Sui, Wenhai; Li, Hongshi; Yang, Yunlong; Jing, Xu; Xue, Fei; Cheng, Jing; Dong, Mei; Zhang, Meng; Pan, Huazheng; Chen, Yuguo | |
| 2019 | |
| 卷号 | 116期号:22页码:10937-10942 |
| 关键词 | mirabegron atherosclerosis plaque instability lipolysis adipose tissue |
| ISSN号 | 0027-8424 |
| DOI | 10.1073/pnas.1901655116 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6340013 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Sui, Wenhai,Li, Hongshi,Yang, Yunlong,et al. Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis[J],2019,116(22):10937-10942. |
| APA | Sui, Wenhai.,Li, Hongshi.,Yang, Yunlong.,Jing, Xu.,Xue, Fei.,...&Cao, Yihai.(2019).Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis.,116(22),10937-10942. |
| MLA | Sui, Wenhai,et al."Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis".116.22(2019):10937-10942. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论